Severe recurrent Still's disease requiring IL-1 receptor antagonist treatment in a 17 old woman

被引：0
|
作者：
Schneeberger, D. [1 ]
Devaud, E. [2 ]
Ruffieux, C. [3 ]
Grognuz, F. [1 ]
Spertini, F. [4 ]
机构：
[1] Cabinet Prive, Fribourg, Switzerland
[2] Cabinet Prive, Givisiez, Switzerland
[3] Cabinet Prive, Villars Sur Glane, Switzerland
[4] CHUV, Lausanne, Switzerland
来源：
SWISS MEDICAL WEEKLY | 2008年 / 138卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：59S / 59S
页数：1
相关论文
共 50 条
  • [21] Successful treatment of adult-onset Still's disease refractory to TNF and IL-1 blockade by IL-6 receptor blockade
    Rech, Juergen
    Ronneberger, Monika
    Englbrecht, Matthias
    Finzel, Stephanie
    Katzenbeisser, Julia
    Manger, Karin
    Manger, Bernhard
    Schett, Georg
    ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (02) : 390 - U187
  • [22] Inflammatory bowel disease: No association between allelic polymorphisms of IL-1 beta and IL-1 receptor antagonist genes
    Bidlingmaier, C
    Hacker, UT
    Gomolka, M
    Keller, E
    Eigler, A
    Folwaczny, C
    Fricke, H
    Albert, E
    Loeschke, K
    Endres, S
    GASTROENTEROLOGY, 1997, 112 (04) : A935 - A935
  • [23] IL-1 Receptor Antagonist Improves Mortality in Severe Sepsis Subset with hemophagocytic Syndrome
    Shakoory, Bita
    Carcillo, Joseph
    Zhao Huaqing
    Cron, Randall
    Dinarello, Charles
    Opal, Steven
    CRITICAL CARE MEDICINE, 2013, 41 (12)
  • [24] Effect of the IL-1 Receptor Antagonist Kineret® on Disease Phenotype in mdx Mice
    Klimek, Margaret E. Benny
    Sali, Arpana
    Rayavarapu, Sree
    Van der Meulen, Jack H.
    Nagaraju, Kanneboyina
    PLOS ONE, 2016, 11 (05):
  • [25] IL-1 receptor antagonist gene polymorphism is associated with Barrett's esophagus
    Moons, LMG
    Van Vliet, AHM
    Geldof, H
    Bode, WA
    Kuipers, EJ
    Kusters, JG
    Siersema, PD
    GASTROENTEROLOGY, 2003, 124 (04) : A635 - A635
  • [26] IL-1 receptor antagonist plus pentoxifylline and zinc for severe alcohol-associated hepatitis
    Szabo, Gyongyi
    Mitchell, Mack
    McClain, Craig J.
    Dasarathy, Srinivasan
    Barton, Bruce
    McCullough, Arthur J.
    Nagy, Laura E.
    Kroll-Desrosiers, Aimee
    Tornai, David
    Min, Hyesung Alice
    Radaeva, Svetlana
    Holbein, M. E. Blair
    Casey, Lisa
    Cuthbert, Jennifer
    HEPATOLOGY, 2022, 76 (04) : 1058 - 1068
  • [27] Incessant myopericarditis after mRNA vaccination requiring IL-1 receptor antagonist therapy and pericardiectomy: case report
    Hay, Michael B.
    Muthalaly, Rahul G.
    Tan, Sean
    Nerlekar, Nitesh
    EUROPEAN HEART JOURNAL-CASE REPORTS, 2023, 7 (09)
  • [28] Intravenous IL-1 Receptor Antagonist for Prevention of Severe Immune Effector CellAssociated Neurotoxicity Syndrome
    Park, Sunmin
    Hannigan, Christopher
    Tuscano, Joseph M.
    Timmerman, John
    Oliai, Caspian H.
    BLOOD, 2023, 142
  • [29] The reduction of concomitant glucocorticoids dosage following treatment with IL-1 receptor antagonist in adult onset Still's disease. A systematic review and meta-analysis of observational studies
    Ruscitti, Piero
    Ursini, Francesco
    Sota, Jurgen
    De Giorgio, Roberto
    Cantarini, Luca
    Giacomelli, Roberto
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2020, 12
  • [30] A Novel Autoinflammatory Disease Due to Homozygous Deletion of the IL-1RN locus; Effective Treatment with Recombinant IL-1 Receptor Antagonist
    Verbsky, J.
    Reddy, S.
    Suchi, M.
    Broeckel, U.
    Hessner, M.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (03) : 728 - 728
12345